Ho Yeong Lim

2 ta ish

Samsung Medical Center

1. Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours

   David S. Hong, Yoon‐Koo Kang, Mitesh J. Borad +20

   MaqolaOAOchiq kirish20206 iqtibos

   ABIABI:AkademIndex/2026.other.213689

2. Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer

   Jeong Heo, Tony Reid, Leyo Ruo +23

   MaqolaOAOchiq kirish20132 iqtibos

   ABIABI:AkademIndex/2026.other.047635